oricpharma.com (ORIC) Company Sales Revenue

ORIC Pharmaceuticals possesses significant pricing power due to its development of methods to combat tumor drug resistance. On GURU.Markets, the company's total sales are presented via a line chart, where the value 0.00 indicates the current figure. US laboratories and a strong team of experts ensure business stability, although its pre-commercial status requires substantial expenditures on clinical trials without operating leverage.

ORIC ORIC Pharmaceuticals, Inc. Revenue and Sales Volume (07/04/2022 - 11/13/2026)

Comprehensive metric breakdowns and analytics for ORIC Pharmaceuticals, Inc. (ORIC)

- price and consensus price forecast:

Stock Price ORIC Corp|ORIC - Price Target Chart

- market capitalization details:

Market Value ORIC Pharmaceuticals, Inc.|ORIC - Enterprise Value

- balance sheet net asset value indicators:

Book Value of One Share ORIC Pharmaceuticals|ORIC - Book Capitalization|Market-to-Book Ratio oricpharma.com|ORIC - Cumulative Company Assets

- debt and solvency information:

Aggregate Debt to Capital ORIC Pharmaceuticals|ORIC - Long-Term Debt to Capital|Current Liabilities to Capital ORIC Pharmaceuticals Inc|ORIC - Company Aggregate Debts|Debt to Book Value Ratio ORIC Pharmaceuticals, Inc.|ORIC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ORIC Pharmaceuticals|Intermediate Liquidity Ratio oricpharma.com

- earnings and multiples data:

ORIC - Net Profit|Expected Net Income ORIC Pharmaceuticals|ORIC - P/E Multiple|Projected Price to Earnings Ratio oricpharma.com|ORIC - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation ORIC Pharmaceuticals, Inc.|ORIC - Operating profit EBITDA|Net earnings per share (EPS TTM) ORIC Pharmaceuticals|ORIC - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months oricpharma.com|ORIC - Net earnings per share growth this year|Expected net earnings per share growth next year ORIC Pharmaceuticals

- company sales and revenue statistics:

ORIC - Company Revenue|Company Expected Sales Volume ORIC Corp|ORIC - Price-to-Revenue Ratio|Forward Price to Sales ORIC Pharmaceuticals, Inc.

Summary company analysis:ORIC Corp ORIC

Finished products of ORIC Pharmaceuticals

High R&D expenditures at ORIC Pharmaceuticals for oncology drugs are creating significant pressure on liquidity. This indicator captures actual daily cash inflows from sales, excluding market speculation. For the investor, this serves as a tool for the real-time assessment of the business's operational viability. The stability or stagnation of these values determines the company's stage of development. By analyzing the total sales of ORIC Pharmaceuticals, one can differentiate actual revenue from hypothetical expectations.

Competing companies